Dutch otolaryngologist Marein van der Torn hoped to develop a prosthesis that would improve the voice of people who had lost their vocal cords. He investigated the possibilities of a new type of voice ...
Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
- Key vendors in voice prosthesis devices market focus on longevity and cost-effectiveness of voice prosthesis, improving cancer care for laryngectomy key target - Market to reach valuation of US$190 ...
ALBANY, N.Y., March 4, 2021 /PRNewswire/ -- Voice prosthesis devices are gaining clinical acceptance for speech rehabilitation in patients, especially in patients with laryngeal and hypopharyngeal ...